Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
May 08, 2024 16:03 ET
|
Seer, Inc.
New Seer Technology Access Center to open in Bonn, Germany Provides life sciences researchers conducting proteomic studies full-service access to the Seer Proteograph™ Product Suite and mass...
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
May 08, 2024 16:02 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
HighPeak Energy, Inc. Announces First Quarter 2024 Financial and Operating Results
May 08, 2024 16:02 ET
|
HighPeak Energy, Inc.
HighPeak Energy, Inc. Announces First Quarter 2024 Financial and Operating Results
Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 08, 2024 16:02 ET
|
Olema Oncology
Completed enrollment in 60-patient Phase 1b/2 clinical studies of palazestrant in combination with each of ribociclib and palbociclibNew clinical data from palazestrant-ribociclib combination study to...
Green Thumb Industries Reports First Quarter 2024 Results
May 08, 2024 16:02 ET
|
Green Thumb Industries
CHICAGO and VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis...
Monroe Capital Corporation BDC Announces First Quarter 2024 Results
May 08, 2024 16:01 ET
|
Monroe Capital Corporation
CHICAGO, May 08, 2024 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (NASDAQ: MRCC) (“Monroe”) today announced its financial results for the first quarter ended March 31, 2024. Except where the...
Sunrun Reports First Quarter 2024 Financial Results
May 08, 2024 16:01 ET
|
Sunrun Inc.
Sunrun Reports First Quarter 2024 Financial Results
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress
May 08, 2024 16:01 ET
|
Bionano Genomics
Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023Total installed base of 347 optical genome mapping (OGM) systems as of Q1 2024, which represents a 34% increase over Q1...
Standard BioTools Reports First Quarter 2024 Financial Results
May 08, 2024 16:01 ET
|
Standard BioTools Inc.
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025Delivered pro forma combined revenue of $46.2 million,...
SLR Investment Corp. Announces Quarter Ended March 31, 2024 Financial Results
May 08, 2024 16:01 ET
|
SLR Investment Corp.
Net Investment Income of $0.44 Per Share; Declared Quarterly Distribution of $0.41 Per Share; NAV Appreciation and Solid Portfolio Credit Quality NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- SLR...